{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:19:04Z","timestamp":1788031144049,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the Innovation Fund of the Joint Federal Committee","award":["01VSF18015"],"award-info":[{"award-number":["01VSF18015"]}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40273-020-00991-7","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T01:02:24Z","timestamp":1611018144000},"page":"287-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-7225","authenticated-orcid":false,"given":"Marina","family":"Treskova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pozo-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Sch\u00f6nfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"1","key":"991_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/jinf.2001.1016","volume":"45","author":"CL Collins","year":"2002","unstructured":"Collins CL, Pollard AJ. Respiratory syncytial virus infections in children and adults. J Infect. 2002;45(1):10\u20137. https:\/\/doi.org\/10.1053\/jinf.2001.1016.","journal-title":"J Infect"},{"issue":"6","key":"991_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpedi.1986.02140200053026","volume":"140","author":"WP Glezen","year":"1986","unstructured":"Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543\u20136. https:\/\/doi.org\/10.1001\/archpedi.1986.02140200053026.","journal-title":"Am J Dis Child."},{"key":"991_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0283-x","author":"P Poletti","year":"2015","unstructured":"Poletti P, Merler S, Ajelli M, Manfredi P, Munywoki PK, James Nokes D, et al. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings. BMC Med. 2015. https:\/\/doi.org\/10.1186\/s12916-015-0283-x.","journal-title":"BMC Med"},{"key":"991_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1874285801105010144","volume":"5","author":"C Sommer","year":"2011","unstructured":"Sommer C, Resch B, Simoes EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5:144\u201354. https:\/\/doi.org\/10.2174\/1874285801105010144.","journal-title":"Open Microbiol J"},{"issue":"10098","key":"991_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/s0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946\u201358. https:\/\/doi.org\/10.1016\/s0140-6736(17)30938-8.","journal-title":"Lancet"},{"issue":"3","key":"991_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5409\/wjcp.v1.i3.8","volume":"1","author":"B Resch","year":"2012","unstructured":"Resch B. Burden of respiratory syncytial virus infection in young children. World J Clin Pediatr. 2012;1(3):8\u201312. https:\/\/doi.org\/10.5409\/wjcp.v1.i3.8.","journal-title":"World J Clin Pediatr."},{"key":"991_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1874285801408010071","volume":"8","author":"B Resch","year":"2014","unstructured":"Resch B. respiratory syncytial virus infection in high-risk infants\u2014an update on Palivizumab prophylaxis. Open Microbiol J. 2014;8:71\u20137. https:\/\/doi.org\/10.2174\/1874285801408010071.","journal-title":"Open Microbiol J"},{"issue":"1","key":"991_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pai.13131","volume":"31","author":"A Mejias","year":"2020","unstructured":"Mejias A, Wu B, Tandon N, Chow W, Varma R, Franco E, et al. Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full-term infants. Pediatr Allergy Immunol. 2020;31(1):47\u201356. https:\/\/doi.org\/10.1111\/pai.13131.","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"991_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.23736\/s0026-4946.18.05327-6","volume":"70","author":"E Priante","year":"2018","unstructured":"Priante E, Cavicchiolo ME, Baraldi E. RSV infection and respiratory sequelae. Minerva Pediatr. 2018;70(6):623\u201333. https:\/\/doi.org\/10.23736\/s0026-4946.18.05327-6.","journal-title":"Minerva Pediatr."},{"issue":"4","key":"991_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.9745\/GHSP-D-19-00121","volume":"7","author":"B Gonik","year":"2019","unstructured":"Gonik B. The burden of respiratory syncytial virus infection in adults and reproductive-aged women. Glob Health Sci Pract. 2019;7(4):515\u201320. https:\/\/doi.org\/10.9745\/GHSP-D-19-00121.","journal-title":"Glob Health Sci Pract."},{"key":"991_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw270","author":"ST Pastula","year":"2017","unstructured":"Pastula ST, Hackett J, Coalson J, Jiang X, Villafana T, Ambrose C, et al. Hospitalizations for respiratory syncytial virus among adults in the United States, 1997\u20132012. Open forum Infect Dis. 2017. https:\/\/doi.org\/10.1093\/ofid\/ofw270.","journal-title":"Open forum Infect Dis."},{"issue":"6","key":"991_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.medmal.2018.01.008","volume":"48","author":"N Haber","year":"2018","unstructured":"Haber N. Respiratory syncytial virus infection in elderly adults. Med Mal Infect. 2018;48(6):377\u201382. https:\/\/doi.org\/10.1016\/j.medmal.2018.01.008.","journal-title":"Med Mal Infect."},{"issue":"7","key":"991_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","volume":"22","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005;22(7):577\u201387. https:\/\/doi.org\/10.2165\/00002512-200522070-00004.","journal-title":"Drugs Aging"},{"issue":"3","key":"991_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/irv.12723","volume":"14","author":"M Smithgall","year":"2020","unstructured":"Smithgall M, Maykowski P, Zachariah P, Oberhardt M, Vargas CY, Reed C, et al. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital. Influ Other Respir Viruses. 2020;14(3):247\u201356. https:\/\/doi.org\/10.1111\/irv.12723.","journal-title":"Influ Other Respir Viruses."},{"key":"991_CR15","first-page":"84","volume-title":"Passive immunization. Plotkin's vaccines","author":"MKA Slifka","year":"2017","unstructured":"Slifka MKA. Passive immunization. Plotkin\u2019s vaccines. 7th ed. Amsterdam: Elsevier; 2017. p. 84\u201395.","edition":"7"},{"key":"991_CR16","first-page":"16","volume-title":"Vaccine immunology. Plotkin's vaccines","author":"CA Siegrist","year":"2017","unstructured":"Siegrist CA. Vaccine immunology. Plotkin\u2019s vaccines. 7th ed. Amsterdam: Elsevier; 2017. p. 16\u201334.","edition":"7"},{"key":"991_CR17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-4064","author":"S Mac","year":"2019","unstructured":"Mac S, Sumner A, Duchesne-Belanger S, Stirling R, Tunis M, Sander B. Cost-effectiveness of Palivizumab for respiratory syncytial virus: a systematic review. Pediatrics. 2019. https:\/\/doi.org\/10.1542\/peds.2018-4064.","journal-title":"Pediatrics"},{"issue":"10","key":"991_CR18","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/s1473-3099(18)30292-5","volume":"18","author":"NI Mazur","year":"2018","unstructured":"Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018;18(10):e295\u2013311. https:\/\/doi.org\/10.1016\/s1473-3099(18)30292-5.","journal-title":"Lancet Infect Dis"},{"key":"991_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1472-6963-8-270","volume":"8","author":"MM Goetghebeur","year":"2008","unstructured":"Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Evidence and Value: Impact on DEcisionMaking\u2014the EVIDEM framework and potential applications. BMC Health Serv Res. 2008;8:270. https:\/\/doi.org\/10.1186\/1472-6963-8-270.","journal-title":"BMC Health Serv Res"},{"issue":"15","key":"991_CR20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0264-410X(99)00425-9","volume":"18","author":"BD Gessner","year":"2000","unstructured":"Gessner BD. The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly. Vaccine. 2000;18(15):1485\u201394. https:\/\/doi.org\/10.1016\/S0264-410X(99)00425-9.","journal-title":"Vaccine."},{"issue":"9","key":"991_CR21","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.17654\/MS102091865","volume":"102","author":"ES Nugraha","year":"2017","unstructured":"Nugraha ES, Nuraini N. Simple vaccination and prevention model of respiratory syncytial virus. Far East J Math Sci. 2017;102(9):1865\u201380. https:\/\/doi.org\/10.17654\/MS102091865.","journal-title":"Far East J Math Sci."},{"issue":"2","key":"991_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vaccine.2019.10.023","volume":"38","author":"G Rainisch","year":"2020","unstructured":"Rainisch G, Adhikari B, Meltzer MI, Langley G. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants. Vaccine. 2020;38(2):251\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.023.","journal-title":"Vaccine."},{"issue":"40","key":"991_CR23","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1016\/j.vaccine.2013.07.024","volume":"31","author":"SA R\u00e9gnier","year":"2013","unstructured":"R\u00e9gnier SA. Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine. Vaccine. 2013;31(40):4347\u201354. https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.024.","journal-title":"Vaccine."},{"issue":"46","key":"991_CR24","doi-asserted-by":"publisher","first-page":"13239","DOI":"10.1073\/pnas.1522597113","volume":"113","author":"D Yamin","year":"2016","unstructured":"Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, et al. Vaccination strategies against respiratory syncytial virus. Proc Natl Acad Sci USA. 2016;113(46):13239\u201344. https:\/\/doi.org\/10.1073\/pnas.1522597113.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"991_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1017\/S0950268809991373","volume":"138","author":"L Acedo","year":"2010","unstructured":"Acedo L, D\u00edez-Domingo J, Mora\u00f1o JA, Villanueva RJ. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010;138(6):853\u201360. https:\/\/doi.org\/10.1017\/S0950268809991373.","journal-title":"Epidemiol Infect"},{"issue":"7\u20138","key":"991_CR26","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.mcm.2010.02.041","volume":"52","author":"L Acedo","year":"2010","unstructured":"Acedo L, Mora\u00f1o JA, D\u00edez-Domingo J. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model. Math Comput Model. 2010;52(7\u20138):1016\u201322. https:\/\/doi.org\/10.1016\/j.mcm.2010.02.041.","journal-title":"Math Comput Model."},{"issue":"1","key":"991_CR27","first-page":"159","volume":"41","author":"M Jornet-Sanz","year":"2017","unstructured":"Jornet-Sanz M, Corber\u00e1n-Vallet A, Santonja FJ, Villanueva RJ. A Bayesian stochastic SIRS model with a vaccination strategy for the analysis of respiratory syncytial virus. SORT. 2017;41(1):159\u201376.","journal-title":"SORT."},{"issue":"39\u201340","key":"991_CR28","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1016\/j.vaccine.2007.07.006","volume":"25","author":"JM Bos","year":"2007","unstructured":"Bos JM, Rietveld E, Moll HA, Steyerberg EW, Luytjes W, Wilschut JC, et al. The use of health economics to guide drug development decisions: determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach. Vaccine. 2007;25(39\u201340):6922\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.006.","journal-title":"Vaccine."},{"issue":"52","key":"991_CR29","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1016\/j.vaccine.2013.10.023","volume":"31","author":"MJ Meijboom","year":"2013","unstructured":"Meijboom MJ, Pouwels KB, Luytjes W, Postma MJ, Hak E. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population. Vaccine. 2013;31(52):6254\u201360. https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.023.","journal-title":"Vaccine."},{"issue":"31","key":"991_CR30","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1016\/j.vaccine.2012.04.072","volume":"30","author":"MJ Meijboom","year":"2012","unstructured":"Meijboom MJ, Rozenbaum MH, Benedictus A, Luytjes W, Kneyber MCJ, Wilschut JC, et al. Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands. Vaccine. 2012;30(31):4691\u2013700. https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.072.","journal-title":"Vaccine."},{"key":"991_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa424","author":"M van Boven","year":"2020","unstructured":"van Boven M, Teirlinck AC, Meijer A, Hooiveld M, van Dorp CH, Reeves RM, et al. Estimating transmission parameters for respiratory syncytial virus and predicting the impact of maternal and pediatric vaccination. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa424.","journal-title":"J Infect Dis"},{"issue":"8","key":"991_CR32","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/S2468-2667(17)30103-2","volume":"2","author":"D Cromer","year":"2017","unstructured":"Cromer D, van Hoek AJ, Newall AT, Pollard AJ, Jit M. Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England. Lancet Public Health. 2017;2(8):e367\u201374. https:\/\/doi.org\/10.1016\/S2468-2667(17)30103-2.","journal-title":"Lancet Public Health."},{"key":"991_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2020.100055","author":"T Kinyanjui","year":"2020","unstructured":"Kinyanjui T, Pan-Ngum W, Saralamba S, Taylor S, White L, Nokes DJ. Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting. Vaccine X. 2020. https:\/\/doi.org\/10.1016\/j.jvacx.2020.100055.","journal-title":"Vaccine X."},{"issue":"45","key":"991_CR34","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1016\/j.vaccine.2017.09.043","volume":"35","author":"AB Hogan","year":"2017","unstructured":"Hogan AB, Campbell PT, Blyth CC, Lim FJ, Fathima P, Davis S, et al. Potential impact of a maternal vaccine for RSV: a mathematical modelling study. Vaccine. 2017;35(45):6172\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.043.","journal-title":"Vaccine."},{"key":"991_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163567","author":"KB Pouwels","year":"2016","unstructured":"Pouwels KB, Bozdemir SE, Yegenoglu S, Celebi S, McIntosh ED, Unal S, et al. Potential cost-effectiveness of RSV vaccination of infants and pregnant women in Turkey: An illustration based on bursa data. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0163567.","journal-title":"PLoS ONE"},{"key":"991_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138018","author":"TM Kinyanjui","year":"2015","unstructured":"Kinyanjui TM, House TA, Kiti MC, Cane PA, Nokes DJ, Medley GF. Vaccine induced herd immunity for control of respiratory syncytial virus disease in a low-income country setting. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0138018.","journal-title":"PLoS ONE"},{"issue":"2","key":"991_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.vaccine.2016.10.073","volume":"35","author":"W Pan-Ngum","year":"2017","unstructured":"Pan-Ngum W, Kinyanjui T, Kiti M, Taylor S, Toussaint JF, Saralamba S, et al. Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: a consensus modelling approach. Vaccine. 2017;35(2):403\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.073.","journal-title":"Vaccine."},{"key":"991_CR38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47003","author":"SPC Brand","year":"2020","unstructured":"Brand SPC, Munywoki P, Walumbe D, Keeling MJ, Nokes DJ. Reducing RSV hospitalisation in a lower-income country by vaccinating mothers-to-be and their households. eLife. 2020. https:\/\/doi.org\/10.7554\/eLife.47003.","journal-title":"eLife."},{"issue":"33","key":"991_CR39","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1016\/j.vaccine.2020.06.036","volume":"38","author":"R Baral","year":"2020","unstructured":"Baral R, Li X, Willem L, Antillon M, Vilajeliu A, Jit M, et al. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models. Vaccine. 2020;38(33):5139\u201347. https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.036.","journal-title":"Vaccine."},{"key":"991_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01537-6","author":"X Li","year":"2020","unstructured":"Li X, Willem L, Antillon M, Bilcke J, Jit M, Beutels P. Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC Medicine. 2020. https:\/\/doi.org\/10.1186\/s12916-020-01537-6.","journal-title":"BMC Medicine."},{"issue":"2","key":"991_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0025-5564(01)00066-9","volume":"172","author":"A Weber","year":"2001","unstructured":"Weber A, Weber M, Milligan P. Modeling epidemics caused by respiratory syncytial virus (RSV). Math Biosci. 2001;172(2):95\u2013113. https:\/\/doi.org\/10.1016\/S0025-5564(01)00066-9.","journal-title":"Math Biosci"},{"issue":"Suppl 1","key":"991_CR42","doi-asserted-by":"publisher","first-page":"A64-A","DOI":"10.1186\/1710-1492-10-S1-A64","volume":"10","author":"LMC Roy","year":"2014","unstructured":"Roy LMC, Bansback N, Marra C, Carr R, Chilvers M, Lynd LD. Evaluating preferences for long term wheeze following RSV infection using TTO and best-worst scaling. Allergy Asthma Clin Immunol. 2014;10(Suppl 1):A64-A. https:\/\/doi.org\/10.1186\/1710-1492-10-S1-A64.","journal-title":"Allergy Asthma Clin Immunol."},{"key":"991_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1477-7525-3-17","volume":"3","author":"GM Lee","year":"2005","unstructured":"Lee GM, Salomon JA, LeBaron CW, Lieu TA. Health-state valuations for pertussis: methods for valuing short-term health states. Health Qual Life Outcomes. 2005;3:17. https:\/\/doi.org\/10.1186\/1477-7525-3-17.","journal-title":"Health Qual Life Outcomes."},{"issue":"1","key":"991_CR44","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12879-014-0544-x","volume":"14","author":"J D\u00edez-Domingo","year":"2014","unstructured":"D\u00edez-Domingo J, P\u00e9rez-Yarza EG, Melero JA, S\u00e1nchez-Luna M, Aguilar MD, Blasco AJ, et al. Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis. 2014;14(1):544. https:\/\/doi.org\/10.1186\/s12879-014-0544-x.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"991_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/01.inf.0000129690.35341.8d","volume":"23","author":"E Rietveld","year":"2004","unstructured":"Rietveld E, De Jonge HC, Polder JJ, Vergouwe Y, Veeze HJ, Moll HA, et al. Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk. Pediatr Infect Dis J. 2004;23(6):523\u20139. https:\/\/doi.org\/10.1097\/01.inf.0000129690.35341.8d.","journal-title":"Pediatr Infect Dis J."},{"issue":"9","key":"991_CR46","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/606055","volume":"49","author":"DJ Nokes","year":"2009","unstructured":"Nokes DJ, Ngama M, Bett A, Abwao J, Munywoki P, English M, et al. Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis. 2009;49(9):1341\u20139. https:\/\/doi.org\/10.1086\/606055.","journal-title":"Clin Infect Dis."},{"issue":"1","key":"991_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1532-5415.1995.tb06238.x","volume":"43","author":"AR Falsey","year":"1995","unstructured":"Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995;43(1):30\u20136. https:\/\/doi.org\/10.1111\/j.1532-5415.1995.tb06238.x.","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"991_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1532-5415.1992.tb01929.x","volume":"40","author":"AR Falsey","year":"1992","unstructured":"Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992;40(2):115\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.1992.tb01929.x.","journal-title":"J Am Geriatr Soc."},{"issue":"6","key":"991_CR49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/oxfordjournals.aje.a116348","volume":"135","author":"MM Jackson","year":"1992","unstructured":"Jackson MM, Fierer J, Barrett-Connor E, Fraser D, Klauber MR, Hatch R, et al. Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol. 1992;135(6):685\u201396. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116348.","journal-title":"Am J Epidemiol."},{"issue":"7115","key":"991_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/bmj.315.7115.1060","volume":"315","author":"KG Nicholson","year":"1997","unstructured":"Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315(7115):1060\u20134. https:\/\/doi.org\/10.1136\/bmj.315.7115.1060.","journal-title":"BMJ"},{"issue":"8","key":"991_CR51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jclinepi.2007.08.017","volume":"61","author":"AG Jansen","year":"2008","unstructured":"Jansen AG, Sanders EA, Wallinga J, Groen EJ, van Loon AM, Hoes AW, et al. Rate-difference method proved satisfactory in estimating the influenza burden in primary care visits. J Clin Epidemiol. 2008;61(8):803\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.08.017.","journal-title":"J Clin Epidemiol."},{"issue":"6","key":"991_CR52","first-page":"447","volume":"69","author":"DA Wilfret","year":"2008","unstructured":"Wilfret DA, Baker BT, Palavecino E, Moran C, Benjamin DK Jr. Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons. N C Med J. 2008;69(6):447\u201352.","journal-title":"N C Med J"},{"issue":"9","key":"991_CR53","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/aje\/kws257","volume":"176","author":"EO Ohuma","year":"2012","unstructured":"Ohuma EO, Okiro EA, Ochola R, Sande CJ, Cane PA, Medley GF, et al. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol. 2012;176(9):794\u2013802. https:\/\/doi.org\/10.1093\/aje\/kws257.","journal-title":"Am J Epidemiol."},{"issue":"2","key":"991_CR54","first-page":"130","volume":"55","author":"M Hacimustafaoglu","year":"2013","unstructured":"Hacimustafaoglu M, Celebi S, Bozdemir SE, Ozgur T, Ozcan I, Guray A, et al. RSV frequency in children below 2 years hospitalized for lower respiratory tract infections. Turk J Pediatr. 2013;55(2):130\u20139.","journal-title":"Turk J Pediatr"},{"issue":"5","key":"991_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/00019053-200422050-00001","volume":"22","author":"LC Paramore","year":"2004","unstructured":"Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics. 2004;22(5):275\u201384. https:\/\/doi.org\/10.2165\/00019053-200422050-00001.","journal-title":"Pharmacoeconomics."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-020-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-020-00991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-020-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T01:09:39Z","timestamp":1613610579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-020-00991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s40273-020-00991-7","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"20 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by Projekt DEAL. This research was supported by the Innovation Fund of the Joint Federal Committee (grant number 01VSF18015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Marina Treskova, Francisco Pozo-Martin, Stefan Scholz, Viktoria Sch\u00f6nfeld, Ole Wichmann, and Thomas Harder have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The data presented in this review were obtained from the included studies, which are cited in the main and supplemental text. All other data generated during the review are presented in the tables in the review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to the conception of the study, the search and selection strategies, and the interpretation of the results. MT, FPM, STS, and VS conducted the searches, selected the studies, extracted the data and evaluated the quality. MT and FPM drafted the manuscript, with input from VS, TH, and OW. STS, VS, TH, and OW critically revised the manuscript and contributed to the final draft. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}